Chester County News and Community Website
PHILADELPHIA, PA — Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced updated data from the ongoing Phase 1/2 clinical trial of investigational SPK-8011 in hemophilia …
Read More
WASHINGTON, D.C. — The Federal Trade Commission has filed an administrative complaint (a public version of which will be available and linked to this news release as soon as possible) …
Read More
MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from …
Read MoreWASHINGTON, D.C. — The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology.
Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat the whole eye, today announced the decision to discontinue the …
Read MoreMALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, announced the publication in Nature Gene Therapy …
Read More